Cover image not available

Costing statement : Imatinib for the treatment of unresectable and/or metastatic gastrointestinal stromal tumours (part review of technology appraisal guidance 86)

National Institute for Health and Clinical Excellence

Publication Data

Title Costing statement : Imatinib for the treatment of unresectable and/or metastatic gastrointestinal stromal tumours (part review of technology appraisal guidance 86)
Alternative Title Imatinib for the treatment of unresectable and/or metastatic gastrointestinal stromal tumours (part review of technology appraisal guidance 86)
Author National Institute for Health and Clinical Excellence
Publisher National Institute for Health and Clinical Excellence
Publication date 0000
Publication location London

Topics

Gastrointestinal stromal tumors :: Chemotherapy :: England :: Cost effectiveness
England

Catalogue Data

OBNB ID GBB586241
ISBN 10 n/a
ISBN 13 n/a
Type BibliographicResource, Book
Dewey Classification 616.99433061

ISBD

P1053 1 online resource (2 pages)
P1042 Includes bibliographical references.

Buy a copy

OBNB doesn't sell books, but you may be able to find a copy at one of these websites:

Costing statement : Imatinib for the treatment of unresectable and/or metastatic gastrointestinal stromal tumours (part review of technology appraisal guidance 86) by National Institute for Health and Clinical Excellence. Published by National Institute for Health and Clinical Excellence. Publication and catalogue information, links to buy online and reader comments.